Regeneron Announces Positive Phase 3 Results For EYLEA HD In Retinal Vein Occlusion Treatment
Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of ...
WATE Knoxville on MSN11h
Morgan County tornado reminds region of previous impact of tornadoes
On Thursday, part of Morgan County was hit by an EF2 tornado, although it is not the first one the county has seen. Just last year, the town of Sunbright was hit by a EF1 tornado, and in 2002, 7 ...
WKRN Nashville on MSN1d
NWS: Jackson, Overton, Putnam counties hit by EF-1 tornado
At least three Middle Tennessee counties were hit by an EF-1 tornado as a severe storm moved across the region Thursday night ...
BioWorld2d
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the ...
Kura, Kyowa Kirin announce KOMET-001 results, FDA feedback for trial designs
Kura Oncology (KURA) and Kyowa Kirin announced topline results from KOMET-001, the Phase 2 registration-directed trial of ziftomenib, a highly ...